Julia J Scialla

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. pmc Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months
    Wendy L St Peter
    University of Minnesota College of Pharmacy, Minneapolis, MN, USA
    BMC Nephrol 14:249. 2013
  2. pmc Choices in kidney transplantation in type 1 diabetes: are there skeletal benefits of the endocrine pancreas?
    Julia J Scialla
    Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th Street, Suite 815, Miami, Florida 33136, USA
    Kidney Int 83:356-8. 2013
  3. pmc Dietary acid load: a novel nutritional target in chronic kidney disease?
    Julia J Scialla
    Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Adv Chronic Kidney Dis 20:141-9. 2013
  4. pmc Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease
    Julia J Scialla
    Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Clin J Am Soc Nephrol 6:2612-9. 2011
  5. pmc Net endogenous acid production is associated with a faster decline in GFR in African Americans
    Julia J Scialla
    Department of Medicine, University of Miami, Miami, Florida 33136, USA
    Kidney Int 82:106-12. 2012
  6. pmc Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study
    Julia J Scialla
    Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
    J Ren Nutr 22:379-388.e1. 2012
  7. pmc Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease
    Julia J Scialla
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Clin J Am Soc Nephrol 6:1526-32. 2011
  8. pmc Mineral metabolites and CKD progression in African Americans
    Julia J Scialla
    Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    J Am Soc Nephrol 24:125-35. 2013
  9. pmc Fibroblast growth factor-23 and cardiovascular events in CKD
    Julia J Scialla
    University of Miami Miller School of Medicine, Miami, Florida
    J Am Soc Nephrol 25:349-60. 2014
  10. pmc An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States
    Julia J Scialla
    Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    Kidney Int 86:798-809. 2014

Detail Information

Publications17

  1. pmc Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months
    Wendy L St Peter
    University of Minnesota College of Pharmacy, Minneapolis, MN, USA
    BMC Nephrol 14:249. 2013
    ....
  2. pmc Choices in kidney transplantation in type 1 diabetes: are there skeletal benefits of the endocrine pancreas?
    Julia J Scialla
    Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th Street, Suite 815, Miami, Florida 33136, USA
    Kidney Int 83:356-8. 2013
    ..It is not known whether the apparent benefit of simultaneous pancreas-kidney transplantation is due to improved bone strength or fewer falls, but these findings may influence transplant decision making...
  3. pmc Dietary acid load: a novel nutritional target in chronic kidney disease?
    Julia J Scialla
    Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Adv Chronic Kidney Dis 20:141-9. 2013
    ..Studies focusing on hard clinical outcomes are needed...
  4. pmc Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease
    Julia J Scialla
    Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Clin J Am Soc Nephrol 6:2612-9. 2011
    ..Osteoprotegerin (OPG), a cytokine that regulates bone resorption, has been implicated in the process of vascular calcification and stiffness...
  5. pmc Net endogenous acid production is associated with a faster decline in GFR in African Americans
    Julia J Scialla
    Department of Medicine, University of Miami, Miami, Florida 33136, USA
    Kidney Int 82:106-12. 2012
    ..10) for composite renal events per 25 mEq/day higher net endogenous acid production was not significant. Hence, our findings implicate endogenous acid production as a potential modifiable risk factor for progressive kidney disease...
  6. pmc Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study
    Julia J Scialla
    Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
    J Ren Nutr 22:379-388.e1. 2012
    ..Protein from plant, as opposed to animal, sources may be preferred in chronic kidney disease (CKD) because of the lower bioavailability of phosphate and lower nonvolatile acid load...
  7. pmc Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease
    Julia J Scialla
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Clin J Am Soc Nephrol 6:1526-32. 2011
    ..We tested the association between estimated NEAP and serum bicarbonate in patients with CKD...
  8. pmc Mineral metabolites and CKD progression in African Americans
    Julia J Scialla
    Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    J Am Soc Nephrol 24:125-35. 2013
    ..In conclusion, abnormalities of mineral metabolism worsen with progressive CKD and associate with higher risk for ESRD among African Americans with hypertensive nephrosclerosis...
  9. pmc Fibroblast growth factor-23 and cardiovascular events in CKD
    Julia J Scialla
    University of Miami Miller School of Medicine, Miami, Florida
    J Am Soc Nephrol 25:349-60. 2014
    ..Thus, higher FGF-23 is independently associated with greater risk of cardiovascular events, particularly CHF, in patients with CKD stages 2-4. ..
  10. pmc An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States
    Julia J Scialla
    Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    Kidney Int 86:798-809. 2014
    ..73 m(2); and 0.973 per 1 ml/min per 1.73 m(2) for eGFR 14-20 ml/min per 1.73 m(2)). Thus, there was no associated harm or benefit with early dialysis initiation in the United States. ..
  11. pmc Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD
    Deidra C Crews
    Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Md Electronic address
    Am J Kidney Dis 63:806-15. 2014
    ..Previous observational studies examining outcomes associated with the timing of dialysis therapy initiation in the United States have often been limited by lead time and survivor bias...
  12. pmc Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
    Julia J Scialla
    Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Kidney Int 83:1159-68. 2013
    ..Thus, in contrast to serum phosphate, FGF23 is not associated with arterial calcification and does not promote calcification experimentally. Hence, phosphate and FGF23 promote cardiovascular disease through distinct mechanisms...
  13. pmc Biomarkers of vascular calcification and mortality in patients with ESRD
    Julia J Scialla
    Department of Medicine, University of Miami, Miami, Florida, Department of Epidemiology, Department of Biostatistics, and, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, Department of Medicine, San Francisco General Hospital and University of California San Francisco, San Francisco, California, Department of Epidemiology, Emory University, Atlanta, Georgia, Nephrology Center of Maryland, Baltimore, Maryland, Hospital for Sick Children, University Health Network and University of Toronto, Toronto, Ontario, Canada
    Clin J Am Soc Nephrol 9:745-55. 2014
    ..Factors such as osteoprotegerin (OPG), osteopontin (OPN), bone morphogenic protein-7 (BMP-7), and fetuin-A are involved in vascular calcification...
  14. pmc Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study
    Bernard G Jaar
    Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
    BMC Nephrol 15:68. 2014
    ..This is the first study that has examined non-cardiac incidental findings in research cardiac computed tomography (CT) of hemodialysis patients and their relationship with patient characteristics...
  15. pmc Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study
    L Ebony Boulware
    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, 2024 E, Monument Street, Baltimore, MD 21205, USA
    BMC Nephrol 13:167. 2012
    ..Evidence is lacking to inform providers' and patients' decisions about many common treatment strategies for patients with end stage renal disease (ESRD)...
  16. pmc Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients
    Julia J Scialla
    Department of Medicine, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    Am J Nephrol 33:224-30. 2011
    ..P-selectin is released by activated platelets and endothelium contributing to inflammation and thrombosis. We evaluated the association between soluble P-selectin and atherosclerotic cardiovascular disease (ASCVD) in dialysis patients...
  17. doi request reprint Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
    Julia J Scialla
    University of Miami Miller School of Medicine, University of Miami, 1120 North West 14th Street, Suite 815, Miami, FL 33136, USA
    Nat Rev Nephrol 10:268-78. 2014
    ....